Global HIV Diagnosis Market – Industry Trends and Forecast to 2028

  • Healthcare
  • Upcoming Report
  • May 2021
  • Global
  • 350 Pages
  • No of Tables: 60
  • No of Figures: 220

Global HIV Diagnosis Market, By Product Type (Consumables, Assay, Kits and Reagents, Other Consumables, Instruments, Software and Services), Test Type (Antibody Tests, CD4 Count, Viral Load, Early Infant and Viral Identification), Application (Diagnostic Laboratories, Hospitals, Blood Banks, Home Care Settings and Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028

HIV Diagnosis MarketMarket Analysis and Insights of HIV Diagnosis Market

Data Bridge Market Research analyses that the HIV diagnosis market will exhibit a CAGR of around 8.86% for the forecast period of 2021-2028. Growing focus and government initiatives to curb down HIV, increasing public and private expenditure for the development of healthcare infrastructure and rising demand for blood donations and blood transfusions are the major factors attributable to the growth of HIV diagnosis market.

HIV, also known as human immunodeficiency virus, is a virus that affects the functioning of cells in the body that provide protection against harmful diseases and infections. HIV infection is transferrable and can be transmitted through contact with infected blood, semen or vaginal fluids. HIV diagnosis is therefore a medical technology that is used to diagnose whether the person is HIV positive or negative.

Upsurge in the prevalence of HIV infection is one of the major factors inducing growth in the demand for HIV diagnosis systems. Rising expenditure for research and development proficiencies by the major healthcare companies coupled with increasing application of HIV antigen, nucleic acid testing and viral load testing will further generate lucrative and remunerative growth opportunities for the market. Rising adoption of advanced healthcare technological solutions coupled with increased initiatives by the government to spread awareness will also act as important market growth determinants.  

However, high costs associated with the HIV diagnosis technological system will derail the market growth rate. Dearth of skilled medical professionals will also create obstructions for the HIV diagnosis market.

This HIV diagnosis market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on HIV diagnosis market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global HIV Diagnosis Market Scope and Market Size

The HIV diagnosis market is segmented on the basis of product type, test type and application. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

  • By product type, the global HIV diagnosis market is segmented into consumables, assay, kits and reagents, other consumables, instruments, software and services.
  • By test type, the global HIV diagnosis market is segmented into antibody tests, CD4 count, viral load, early infant and viral identification. Antibody tests segment is further sub-segmented into HIV-1 screening tests, HIV-1 confirmatory tests and HIV-2 and group- o- diagnostic tests. HIV-1 Screening Tests segment is further bifurcated into ELISA, rapid tests and home access dried blood spot. HIV-1 confirmatory tests segment is further bifurcated into western blot tests, indirect immune fluorescent antibody assays (IFA), line immunoassays (LIA) and radio- immune-precipitation assays (RIPA).
  • On the basis of application, the global HIV diagnosis market is segmented into diagnostic laboratories, hospitals, blood banks, home care settings and others.

HIV Diagnosis Market Country Level Analysis

The HIV diagnosis market is analysed and market size insights and trends are provided by product type, test type and application as referenced above.

The countries covered in the HIV diagnosis market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the HIV diagnosis market owing to the increasing adoption of HIV self-tests kits coupled with rising demand for efficient healthcare services. Asia-Pacific on the other hand is projected to undergo the highest growth rate during the forecast period owing to the high prevalence of HIV infection and improving healthcare infrastructure.     

The country section of the HIV diagnosis market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure growth Installed base and New Technology Penetration

HIV diagnosis market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for digital health technologies market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the HIV diagnosis market. The data is available for historic period 2010 to 2019.

Competitive Landscape and HIV Diagnosis Market Share Analysis

The HIV diagnosis market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to HIV diagnosis market.

The major players covered in the HIV diagnosis market report are F. Hoffmann-La Roche Ltd, Abbott, Danaher, Thermo Fisher Scientific, Inc., Merck KGaA, BD, Bio-Rad Laboratories, Inc., Hologic, Inc., QIAGEN, bioMerieux SA, AbbVie Inc., Johnson & Johnson Services Inc., Bristol-Myers Squibb Company, Siemens Healthcare GmbH, Sysmex Corporation, Agilent Technologies, Inc., PointCare, Sysmex Europe GmbH., Quest Diagnostics Incorporated. and Gilead Sciences, Inc. among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Customization Available : Global HIV Diagnosis Market

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.


Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Frequently Asked Questions